\documentclass[10pt,a4paper]{article} % Packages \usepackage{fancyhdr} % For header and footer \usepackage{multicol} % Allows multicols in tables \usepackage{tabularx} % Intelligent column widths \usepackage{tabulary} % Used in header and footer \usepackage{hhline} % Border under tables \usepackage{graphicx} % For images \usepackage{xcolor} % For hex colours %\usepackage[utf8x]{inputenc} % For unicode character support \usepackage[T1]{fontenc} % Without this we get weird character replacements \usepackage{colortbl} % For coloured tables \usepackage{setspace} % For line height \usepackage{lastpage} % Needed for total page number \usepackage{seqsplit} % Splits long words. %\usepackage{opensans} % Can't make this work so far. Shame. Would be lovely. \usepackage[normalem]{ulem} % For underlining links % Most of the following are not required for the majority % of cheat sheets but are needed for some symbol support. \usepackage{amsmath} % Symbols \usepackage{MnSymbol} % Symbols \usepackage{wasysym} % Symbols %\usepackage[english,german,french,spanish,italian]{babel} % Languages % Document Info \author{ksellybelly} \pdfinfo{ /Title (cardio-iv-endocarditis-rheumatic-pvd.pdf) /Creator (Cheatography) /Author (ksellybelly) /Subject (Cardio IV: Endocarditis, Rheumatic, PVD Cheat Sheet) } % Lengths and widths \addtolength{\textwidth}{6cm} \addtolength{\textheight}{-1cm} \addtolength{\hoffset}{-3cm} \addtolength{\voffset}{-2cm} \setlength{\tabcolsep}{0.2cm} % Space between columns \setlength{\headsep}{-12pt} % Reduce space between header and content \setlength{\headheight}{85pt} % If less, LaTeX automatically increases it \renewcommand{\footrulewidth}{0pt} % Remove footer line \renewcommand{\headrulewidth}{0pt} % Remove header line \renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit % This two commands together give roughly % the right line height in the tables \renewcommand{\arraystretch}{1.3} \onehalfspacing % Commands \newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour \newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols \newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns \newcommand{\tn}{\tabularnewline} % Required as custom column type in use % Font and Colours \definecolor{HeadBackground}{HTML}{333333} \definecolor{FootBackground}{HTML}{666666} \definecolor{TextColor}{HTML}{333333} \definecolor{DarkBackground}{HTML}{663228} \definecolor{LightBackground}{HTML}{FAF8F8} \renewcommand{\familydefault}{\sfdefault} \color{TextColor} % Header and Footer \pagestyle{fancy} \fancyhead{} % Set header to blank \fancyfoot{} % Set footer to blank \fancyhead[L]{ \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{C} \SetRowColor{DarkBackground} \vspace{-7pt} {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}} } \end{tabulary} \columnbreak \begin{tabulary}{11cm}{L} \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Cardio IV: Endocarditis, Rheumatic, PVD Cheat Sheet}}}} \\ \normalsize{by \textcolor{DarkBackground}{ksellybelly} via \textcolor{DarkBackground}{\uline{cheatography.com/19318/cs/2383/}}} \end{tabulary} \end{multicols}} \fancyfoot[L]{ \footnotesize \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{LL} \SetRowColor{FootBackground} \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}} \\ \vspace{-2pt}ksellybelly \\ \uline{cheatography.com/ksellybelly} \\ \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}} \\ \vspace{-2pt}Published 24th July, 2014.\\ Updated 13th May, 2016.\\ Page {\thepage} of \pageref{LastPage}. \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}} \\ \SetRowColor{white} \vspace{-5pt} %\includegraphics[width=48px,height=48px]{dave.jpeg} Measure your website readability!\\ www.readability-score.com \end{tabulary} \end{multicols}} \begin{document} \raggedright \raggedcolumns % Set font size to small. Switch to any value % from this page to resize cheat sheet text: % www.emerson.emory.edu/services/latex/latex_169.html \footnotesize % Small font. \begin{multicols*}{3} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Infective Endocarditis}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Causative organisms} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Staph. aureus, group D strep, enterococci, HACEKs} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Organism in IVDA} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Staph. aureus (tricuspid valve*)} \tn % Row Count 5 (+ 2) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Organisms prosthetic valve endocarditis} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Staph, gram-, fungi (first 2 months) and staph/strep after that} \tn % Row Count 8 (+ 3) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Regurgant valve defect} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Seen in most endocarditis pts, makes them more susceptible} \tn % Row Count 11 (+ 3) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{How infections occur} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Direct intravascular contamination or from bacteremia from surgeries} \tn % Row Count 14 (+ 3) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Classic features} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Osler nodes, Janewar lesions, Roth spots, petechiae, splinter hemorrhages} \tn % Row Count 17 (+ 3) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Duke Criteria} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Used to establish diagnosis} \tn % Row Count 19 (+ 2) % Row 7 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Treatment} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Vancomycin + Ceftriaxone} \tn % Row Count 21 (+ 2) % Row 8 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Indications for Abx Prophylaxis} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}If pts. with prosthetic valves, congenital heart disease, valve disorder, transplants are going to get dental work or surgery} \tn % Row Count 25 (+ 4) % Row 9 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Prophylactic abx} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Amoxicillin} \tn % Row Count 27 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{1.89126 cm} x{3.08574 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Aortic Aneurysms}} \tn % Row 0 \SetRowColor{LightBackground} Definition & Weakness and subsequent dilation of the vessel wall, usually from a genetic defect or atherosclerotic damage to the intima \tn % Row Count 6 (+ 6) % Row 1 \SetRowColor{white} Most common cause & Atherosclerosis (can see in Marfan's or Ehlers-Danlos though) \tn % Row Count 9 (+ 3) % Row 2 \SetRowColor{LightBackground} Classic clinical scenario & Elderly male smoker with CAD, emphysema, and renal impairment \tn % Row Count 12 (+ 3) % Row 3 \SetRowColor{white} Where are they found & 90\% abdominal, 10\% thoracic \tn % Row Count 14 (+ 2) % Row 4 \SetRowColor{LightBackground} Clinical features & Pulsatile abdominal mass +/- abdominal or back pain \tn % Row Count 17 (+ 3) % Row 5 \SetRowColor{white} Symptoms of AAA rupture & Severe back, abdominal, or flank pain. Hypotension + shock \tn % Row Count 20 (+ 3) % Row 6 \SetRowColor{LightBackground} Lab Studies & Abdominal U/S followed by CT w/ contrast \tn % Row Count 22 (+ 2) % Row 7 \SetRowColor{white} Treatment & Endovascular or open surgical repair \tn % Row Count 24 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Giant Cell Arteritis}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Definition} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Systemic inflammatory condition of medium \& large vessels, pts. \textgreater{}50yo, often coexists with PMR} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Most commonly-affected arteries} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Temporal artery} \tn % Row Count 5 (+ 2) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Consequence of not treating aggressively} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Blindness} \tn % Row Count 7 (+ 2) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Clinical Features} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Headache, scalp tenderness, jaw claudication, throat pain, visual abnormalities} \tn % Row Count 10 (+ 3) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Lab Studies} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}ESR + CRP both elevated} \tn % Row Count 12 (+ 2) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Definitive diagnostic} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Temporal artery bx} \tn % Row Count 14 (+ 2) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Treatment} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}High-dose prednisone x few months + ASA} \tn % Row Count 16 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Rheumatic Heart Disease}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Rheumatic Fever} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}A systemic immune response occurring 2-3 weeks after a Beta-hemolytic strep. pharyngitis} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Valve most commonly involved} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Mitral valve (75-80\%), then aortic valve (30\%)} \tn % Row Count 5 (+ 2) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Jones Criteria} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Diagnostic criteria to establish diagnosis} \tn % Row Count 7 (+ 2) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Treatment} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Bedrest, salicylates, IM penicillin, and early treatment of strep pharyngitis for prevention*} \tn % Row Count 10 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{PVD-{}-Chronic Venous Insufficiency}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Definition} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Loss of wall tension in veins, resulting ins tasks of venous blood and often assoc. with a hx of DVT, leg injury, or varicose veins} \tn % Row Count 4 (+ 4) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Clinical Features} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Progressive edema starting at ankle, skin changes, itching, dull pain with standing and ulceration, skin is shiny/thin/atrophic with dark pigmentary change and subcutaneous induration, stasis ulcers above ankle} \tn % Row Count 10 (+ 6) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{General Treatment} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}General: leg elevation, avoidance of sitting/standing, compression hose.} \tn % Row Count 13 (+ 3) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Treatment for Stasis Dermatitis} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Wet compresses, HC cream, Zinc oxide, anti fungal cream (ulcerations may need graft)} \tn % Row Count 16 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{PVD-{}-Varicose veins}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Etiology} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Superficial venous insufficiency and valvular incompetance} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Clinical features} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Dilated, tortuous veins, esp. long saphenous vein} \tn % Row Count 6 (+ 3) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Treatment} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Compression stockings, leg elevation, exercise, laser ablation, endovenous radiofrequency, compression sclerotherapy} \tn % Row Count 10 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{PVD-{}-Peripheral arterial disease}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Etiology} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Atherosclerosis or thromboembolism (trauma, hyper coagulable states, etc.)} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Clinical features} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}lower leg pain with exercise which is relieved by rest (AKA intermittent claudication), progresses later to pain at rest, numbness, tingling, ischemic ulcerations, gangrene} \tn % Row Count 8 (+ 5) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{The "Ps" of extremity occlusion} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Pain, pallor, pulselessness, paresthesias, paralysis, poikilothermia} \tn % Row Count 11 (+ 3) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Lab studies/diagnostics} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Doppler flow studies, ABI,} \tn % Row Count 13 (+ 2) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Treatment} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Cilostazol + antiplatelet rx + lifestyle (NO smoking, more exercise), surgery and revascularization} \tn % Row Count 17 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{PVD-{}-Thrombophlebitis \& DVT}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Thrombophlebitis} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Involves occlusion of a vein + inflammatory changes} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Virchow's Triad} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Stasis + vascular injury + hyper-coagulability (predispose veins)} \tn % Row Count 6 (+ 3) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Most common place to find a DVT} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Lower extremities and pelvis} \tn % Row Count 8 (+ 2) % Row 3 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Risk factors for DVT} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Major surgery (total hip), long plane ride, hormone/contraceptive therapy, prolonged bed rest} \tn % Row Count 11 (+ 3) % Row 4 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Features of superficial thrombophlebitis} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Dull pain, erythema, tenderness, induration. Most common in long saphenous vein.} \tn % Row Count 14 (+ 3) % Row 5 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{Class findings of DVT} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Swelling of the involved area and redness} \tn % Row Count 16 (+ 2) % Row 6 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Diagnostic Studies} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Duplex U/S} \tn % Row Count 18 (+ 2) % Row 7 \SetRowColor{white} \mymulticolumn{1}{x{5.377cm}}{D-Dimer} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Highly sensitive, if \textless{}500 then negative, can r/o DVT} \tn % Row Count 21 (+ 3) % Row 8 \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{Treatment} \tn \mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Anticoagulation with LMWH (Lovenox), or heparin then warfarin} \tn % Row Count 24 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} % That's all folks \end{multicols*} \end{document}